Patient-derived iPSC models for investigating the role of AHDC1 in neurodevelopment of individuals with Xia-Gibbs syndrome

Favorite this paper
How to cite this paper?
Details
  • Presentation type: Poster
  • Track: PhD (Doctorate)
  • Keywords: Xia-Gibbs syndrome; AHDC1; iPSC; Neurodevelopmental disorder; Transcription factor;
  • 1 Human Genome and Stem Cell Research Center – Institute of Biosciences - University of São Paulo. São Paulo - SP, Brazil

Please log in to watch the video

Log in
Abstract

Background: Xia-Gibbs syndrome (XGS, OMIM#615829) is a rare autosomal dominant neurodevelopmental disorder caused by de novo heterozygous pathogenic variants in the AHDC1 gene. AHDC1 encodes a transcription factor (TF) involved in maintaining gene-specific chromatin interactions between enhancers and promotors during early development. Knockout of AHDC1 leads to global hypermethylation, affecting specially the methylation pattern of mesoderm genes. The AHDC1 interactome includes chromatin-modifying complexes, enhancer-binding proteins and zinc-finger TFs. However, many aspects of its functions remain unclear, as well as its involvement in neurodevelopment and the molecular mechanisms underlying XGS. Aim: To establish patient-derived cellular models to evaluate the effects of AHDC1 pathogenic variants on neurodevelopment and elucidate the mechanisms underlying XGS. Methodology: Peripheral blood mononuclear cells (PBMCs) from 13 diagnosed XGS patients were reprogrammed into induced pluripotent stem cells (iPSCs) through nucleofection with non-integrating plasmids encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, and a shRNA for p53 suppression. Quality control included testing for contamination (mycoplasma and STR - PCR), plasmid integration (OriP and EBNA-1 - PCR), somatic copy number variations (CNVs; array-CGH), and presence of germline AHDC1 variants (Sanger sequencing). Pluripotency was assessed by immunofluorescence, RTqPCR and three germ layer differentiation, validated by RTqPCR. Results: All 13 PBMC lines we successfully reprogrammed, generating cell lines with typical iPSC morphology and expression of OCT3/4 and NANOG. No mycoplasma contamination, plasmid integration, or somatic CNVs were detected. Germline AHDC1 variants were confirmed in all lines. By cell morphology, all lines were successfully differentiated into endoderm, mesoderm and ectoderm, although validation by RTqPCR is ongoing. Immunofluorescence for pluripotent markers and cross-contamination analysis is pending. Conclusion: We have developed and characterized iPSC lines from 13 XGS patients. These models will be used for neurodifferentiation and functional studies, in order to investigate the role of AHDC1 in neurodevelopment and the underlying molecular mechanisms of XGS.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!